NATALIA FANANI: Open Payments
NPI 1164124657 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,616 in 104 payments from 26 companies in 2025. Trend: 2023 $249 · 2024 $3,939 · 2025 $2,616
Food & beverage: $2,418Education: $198
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $440 |
| Janssen Biotech, Inc. | 9 | $280 |
| Regeneron Healthcare Solutions, Inc. | 6 | $255 |
| MERZ NORTH AMERICA, INC. | 4 | $224 |
| LEO Pharma Inc. | 7 | $169 |
| UCB, Inc. | 5 | $153 |
| ABBVIE INC. | 10 | $151 |
| GENZYME CORPORATION | 4 | $123 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| Galderma Laboratories, L.P. | 5 | $101 |
Products named: DUPIXENT, CIBINQO, TREMFYA, Bimzelx, ADBRY, NEMLUVIO, Xeomin, SKYRIZI.
Industry payments across CT — which companies pay providers there.
